查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829644

2025年全球凝血標記物市場報告

Coagulation Markers Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，凝血標記市場規模強勁成長，從2024年的11.6億美元成長到2025年的12.4億美元，複合年成長率為6.2%。這段歷史時期的成長可歸因於心血管疾病盛行率的上升、人口老化、外科手術的增加、意識提升的提高和早期診斷的提升、政府的舉措和資金投入，以及醫療基礎設施的不斷擴張。

預計未來幾年凝血標記市場將強勁成長，到2029年將達到15.9億美元，複合年成長率為6.5%。預測期內成長的促進因素包括慢性病盛行率的上升、個人化醫療的普及、全球人口的成長、醫療保健支出的增加以及新興市場的擴張。預測期內的主要趨勢包括人工智慧和機器學習的整合、新型生物標記的開發、增強型照護現場技術、實驗室自動化、穿戴式醫療技術、遠端醫療和遠端監控以及永續的診斷方法。

凝血標記是血液中能夠反映凝血或血液凝固過程的物質。這些標記在診斷和監測各種凝血障礙、評估出血和血栓症形成風險以及指南適當的治療策略方面發揮著重要作用。

用作凝血標誌物的關鍵產品包括 D-二聚體檢測和纖維蛋白原檢測。 D-二聚體檢測是一種血液檢測，用於測量 D-二聚體的存在，D-二聚體是血栓分解過程中形成的蛋白質片段。它們採用螢光免疫分析、酵素結合免疫吸附檢測法(ELISA)、快速檢測法和顆粒增強免疫比濁檢測法等技術，可用於多種檢體類型，包括血漿和全血。應用包括深層靜脈栓塞症血栓形成 (DVT)、肺動脈栓塞(PE)、瀰漫性血管內凝血 (DIC) 和創傷。這些檢測的最終用戶包括醫院、專科診所、學術研究機構和診斷實驗室。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供了凝血標誌物行業的市場統計數據，包括全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的凝血標誌物細分市場、市場趨勢和機遇，以及在凝血標誌物行業取得成功所需的數據。本凝血標誌物市場研究報告對行業現狀和未來進行了全面展望，並對所有必要資訊進行了詳細分析。

我們預測未來五年該市場將成長6.5%，較我們先前對該市場的預測略有下降0.4%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自瑞士和比利時等主要地區的D-二聚體抗體和纖維蛋白原校準標準品徵收關稅直接影響美國，從而導致出血性疾病的診斷準確性降低和檢測成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

由於血液疾病的盛行率不斷上升，預計凝血標記市場將大幅成長。這些疾病涵蓋一系列影響血液正常運作能力的狀況，由於人口老化、認知度提高和診斷能力增強等因素，其盛行率正在上升。凝血標記在這些疾病的診斷和管理中發揮關鍵作用，包括評估血液凝固功能、檢測異常以及監測血友病和血栓症等治療的有效性。例如，白血病基金會在2024年5月報告稱，預計到2035年，澳洲患有血癌和血病的人數將超過27.5萬人，這凸顯了對凝血標誌物日益成長的需求。

凝血標誌物市場的主要企業正專注於開發技術先進的解決方案，例如 D-二聚體套件，以提高診斷血栓相關疾病的速度和準確性。 D-二聚體試劑套件是用於測量深層靜脈栓塞症水平的診斷工具，D-二聚體是血栓溶解過程中產生的蛋白質片段，有助於識別和評估血栓相關疾病，如深部靜脈栓塞和肺動脈栓塞。例如，2024 年 7 月，美國生技公司 Bionotex Inc. 推出了 Vcheck D-dimer 5Tests/Kit。這種專為獸醫設計的免疫診斷工具每個套件提供五項測試來測量 D-二聚體水平，這是血栓形成和分解的關鍵標記。它可用於診斷血栓症、敗血症、DIC 和獸醫診所的其他疾病。

2023年1月，美國生技公司賽默飛世爾科技（Thermo Fisher Scientific）以約28億美元（23億英鎊）收購了Binding Site Group。此次收購旨在增強賽默飛世爾的專業診斷產品組合，增強癌症診斷（尤其是多發性骨髓瘤診斷）能力，並推動不斷擴大的診斷市場的成長。 Binding Site Group是一家英國醫療設備製造商，專門提供凝血標誌物。

凝血標誌物市場由提供凝血標記檢測套組製造和銷售、診斷服務、新型凝血標誌物研發和諮詢服務等服務的企業所獲得的收益所構成。市場價值還包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。凝血標誌物市場還包括血液凝固檢驗套件、就地檢驗設備以及數據管理和分析軟體解決方案的銷售。該市場的價值是“出廠價”，即商品製造商或創造者銷售給其他營業單位（包括下游製造商、經銷商、分銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球固化指標：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球凝血標誌物市場：成長率分析
  • 全球凝血標誌物市場表現：規模與成長，2019-2024
  • 全球凝血標誌物市場預測：規模與成長，2024-2029年，2034年
  • 全球凝血標記：總目標市場（TAM）

第6章 市場細分

  • 全球凝血標記市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • D-二聚體測定
  • 纖維蛋白原測定
  • 全球凝血標記市場（按樣本類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 電漿
  • 全血樣本
  • 其他樣本類型
  • 全球凝血標記市場：按技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 螢光免疫分析法
  • 酵素結合免疫吸附試驗（ELISA）
  • 快速檢測
  • 粒子增強免疫比濁法
  • 全球凝血標記市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 深層靜脈栓塞症（DVT）
  • 肺動脈栓塞（PE）
  • 瀰漫性血管內凝血（DIC）
  • 創傷
  • 其他用途
  • 全球凝血標記市場：按最終用戶、業績和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專科診所
  • 學術研究機構
  • 診斷實驗室
  • 全球凝血標記市場：D-二聚體檢測細分（按類型）、實際及預測（2019-2024 年、2024-2029 年、2034 年）
  • 基於ELISA的D-二聚體檢測
  • 側流免疫檢測D-二聚體檢測
  • 化學冷光免疫檢測D-二聚體檢測
  • 全球凝血標記市場：依纖維蛋白原檢測（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 克勞斯纖維蛋白原測定
  • 功能性纖維蛋白原測定
  • 自動化纖維蛋白原測定

第7章 區域和國家分析

  • 全球凝血標記市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球凝血標記市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 凝血標誌物市場：競爭格局
  • 凝血標誌物市場：公司簡介
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Werfen Group
  • Nihon Kohden Corporation
  • Randox Laboratories Ltd
  • Stago Group
  • Sekisui Diagnostics
  • Helena Laboratories Italia Spa
  • Tulip Diagnostics Ltd
  • Trinity Biotech PLC
  • CTK Biotech Inc.
  • International Technidyne Corporation（ITC）
  • Diazyme Laboratories Inc.
  • AdvaCare Pharma USA（AccuQuik Test Kits）
  • Technoclone GmbH

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年凝血標記市場：提供新機會的國家
  • 2029年凝血標誌物市場：細分市場帶來新機會
  • 2029年凝血標記市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29821u

Coagulation markers are substances in the blood that provide insight into the coagulation or clotting processes. These markers play a crucial role in diagnosing and monitoring various coagulation disorders, assessing the risk of bleeding or thrombosis, and guiding appropriate treatment strategies.

The main products used as coagulation markers include the D-dimer assay and the fibrinogen assay. The D-dimer assay is a blood test that measures the presence of D-dimer, a protein fragment formed when a blood clot breaks down. This test can utilize different sample types such as plasma or whole blood, employing technologies such as fluorescence immunoassay, enzyme-linked immunosorbent assay (ELISA), rapid tests, and particle-enhanced immunoturbidimetric assay. It is applied in conditions such as deep venous thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), trauma, and others. End users of these assays include hospitals, specialty clinics, academic and research institutes, and diagnostic laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The coagulation markers market research report is one of a series of new reports from The Business Research Company that provides coagulation markers market statistics, including coagulation markers industry global market size, regional shares, competitors with a coagulation markers market share, detailed coagulation markers market segments, market trends and opportunities, and any further data you may need to thrive in the coagulation markers industry. This coagulation markers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The coagulation markers market size has grown strongly in recent years. It will grow from $1.16 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to the rising prevalence of cardiovascular diseases, an aging population, increasing surgical procedures, awareness and early diagnosis, government initiatives and funding, and expanding healthcare infrastructure.

The coagulation markers market size is expected to see strong growth in the next few years. It will grow to $1.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to a growing incidence of chronic diseases, rising adoption of personalized medicine, a growing global population, rising healthcare expenditures, and expansion in emerging markets. Major trends in the forecast period include the integration of AI and machine learning, the development of novel biomarkers, enhanced point-of-care technologies, automation in laboratories, wearable health technologies, telehealth and remote monitoring, and sustainable diagnostic practices.

The forecast of 6.5% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on D-dimer antibodies and fibrinogen calibration standards, sourced from key regions such as Switzerland and Belgium, which could lead to reduced accuracy in bleeding disorder diagnoses and higher laboratory testing expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The coagulation markers market is expected to grow significantly due to the increasing prevalence of blood disorders. These disorders encompass various conditions that impact the blood's ability to function properly, and their prevalence is rising due to factors such as aging populations, improved awareness, and enhanced diagnostic capabilities. Coagulation markers play a crucial role in diagnosing and managing these disorders by evaluating clotting function, detecting abnormalities, and monitoring treatment effectiveness for conditions such as hemophilia and thrombosis. For example, the Leukaemia Foundation reported in May 2024 that the number of Australians living with blood cancers or disorders is projected to surpass 275,000 by 2035, highlighting the escalating demand for coagulation markers.

Leading companies in the coagulation markers market are focusing on creating technologically advanced solutions, such as D-dimer kits, to enhance the speed and accuracy of diagnosing blood clot-related conditions. D-dimer kits are diagnostic tools used to measure the levels of D-dimer, a protein fragment produced during the dissolution of a blood clot, which helps in identifying and evaluating clot-related disorders like deep vein thrombosis and pulmonary embolism. For example, in July 2024, Bionote Inc., a US-based biotechnology firm, launched the Vcheck D-dimer 5Tests/Kit. This immunodiagnostic tool, designed for veterinary use, provides five tests per kit to measure D-dimer levels, a key marker for blood clot formation and breakdown. It helps diagnose conditions such as thrombosis, sepsis, and DIC in veterinary clinics.

In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for approximately $2.8 billion (£2.3 billion). This acquisition aims to strengthen Thermo Fisher's Specialty Diagnostics portfolio by enhancing cancer diagnostics, particularly in multiple myeloma, and driving growth in the expanding diagnostics market. The Binding Site Group, a UK-based medical equipment manufacturer, specializes in providing coagulation markers.

Major companies operating in the coagulation markers market are Siemens Healthineers, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Werfen Group, Nihon Kohden Corporation, Randox Laboratories Ltd, Stago Group, Sekisui Diagnostics, Helena Laboratories Italia Spa, Tulip Diagnostics Ltd, Trinity Biotech PLC, CTK Biotech Inc., International Technidyne Corporation (ITC), Diazyme Laboratories Inc., AdvaCare Pharma USA (AccuQuik Test Kits), Technoclone GmbH, BioMedica Diagnostics Inc., Eurolyser Diagnostica GmbH, Goldsite Diagnostics Inc., Hipro Biotechnology Co. Ltd., HYPHEN BioMed

North America was the largest region in the coagulation markers market in 2024. The regions covered in the coagulation markers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coagulation markers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coagulation markers market consists of revenues earned by entities providing services such as manufacturing and distribution of coagulation marker testing kits, diagnostic services, research and development of new coagulation markers, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The coagulation markers market also includes sales of coagulation testing kits, point-of-care testing devices, and software solutions for data management and analysis. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coagulation Markers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coagulation markers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coagulation markers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coagulation markers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: D-Dimer Assay; Fibrinogen Assay
  • 2) By Sample Type: Plasma; Whole Blood Sample; Other Sample Types
  • 3) By Technology: Fluorescence Immunoassay; Enzyme-Linked Immuno Sorbent Assay (ELISA); Rapid Test; Particle Enhanced Immunoturbidimetric Assay
  • 4) By Application: Deep Venous Thrombosis (DVT); Pulmonary Embolism (PE); Disseminated Intravascular Coagulation (DIC); Trauma; Other Applications
  • 5) By End User: Hospital; Specialty Clinics; Academic And Research Institute; Diagnostics Laboratories
  • Subsegments:
  • 1) By D-Dimer Assay: ELISA-Based D-Dimer Assay; Lateral Flow Immunoassay D-Dimer Test; Chemiluminescent Immunoassay D-Dimer Test
  • 2) By Fibrinogen Assay: Clauss Fibrinogen Assay; Functional Fibrinogen Assay; Automated Fibrinogen Assay
  • Companies Mentioned: Siemens Healthineers; Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Quidel Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; Werfen Group; Nihon Kohden Corporation; Randox Laboratories Ltd; Stago Group; Sekisui Diagnostics; Helena Laboratories Italia Spa; Tulip Diagnostics Ltd; Trinity Biotech PLC; CTK Biotech Inc.; International Technidyne Corporation (ITC); Diazyme Laboratories Inc.; AdvaCare Pharma USA (AccuQuik Test Kits); Technoclone GmbH; BioMedica Diagnostics Inc.; Eurolyser Diagnostica GmbH; Goldsite Diagnostics Inc.; Hipro Biotechnology Co. Ltd.; HYPHEN BioMed
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Coagulation Markers Market Characteristics

3. Coagulation Markers Market Trends And Strategies

4. Coagulation Markers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Coagulation Markers Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Coagulation Markers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Coagulation Markers Market Growth Rate Analysis
  • 5.4. Global Coagulation Markers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Coagulation Markers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Coagulation Markers Total Addressable Market (TAM)

6. Coagulation Markers Market Segmentation

  • 6.1. Global Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • D-Dimer Assay
  • Fibrinogen Assay
  • 6.2. Global Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plasma
  • Whole Blood Sample
  • Other Sample Types
  • 6.3. Global Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluorescence Immunoassay
  • Enzyme-Linked Immuno Sorbent Assay (ELISA)
  • Rapid Test
  • Particle Enhanced Immunoturbidimetric Assay
  • 6.4. Global Coagulation Markers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deep Venous Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Disseminated Intravascular Coagulation (DIC)
  • Trauma
  • Other Applications
  • 6.5. Global Coagulation Markers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Specialty Clinics
  • Academic and Research Institute
  • Diagnostics Laboratories
  • 6.6. Global Coagulation Markers Market, Sub-Segmentation Of D-Dimer Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • ELISA-Based D-Dimer Assay
  • Lateral Flow Immunoassay D-Dimer Test
  • Chemiluminescent Immunoassay D-Dimer Test
  • 6.7. Global Coagulation Markers Market, Sub-Segmentation Of Fibrinogen Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clauss Fibrinogen Assay
  • Functional Fibrinogen Assay
  • Automated Fibrinogen Assay

7. Coagulation Markers Market Regional And Country Analysis

  • 7.1. Global Coagulation Markers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Coagulation Markers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Coagulation Markers Market

  • 8.1. Asia-Pacific Coagulation Markers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Coagulation Markers Market

  • 9.1. China Coagulation Markers Market Overview
  • 9.2. China Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Coagulation Markers Market

  • 10.1. India Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Coagulation Markers Market

  • 11.1. Japan Coagulation Markers Market Overview
  • 11.2. Japan Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Coagulation Markers Market

  • 12.1. Australia Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Coagulation Markers Market

  • 13.1. Indonesia Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Coagulation Markers Market

  • 14.1. South Korea Coagulation Markers Market Overview
  • 14.2. South Korea Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Coagulation Markers Market

  • 15.1. Western Europe Coagulation Markers Market Overview
  • 15.2. Western Europe Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Coagulation Markers Market

  • 16.1. UK Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Coagulation Markers Market

  • 17.1. Germany Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Coagulation Markers Market

  • 18.1. France Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Coagulation Markers Market

  • 19.1. Italy Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Coagulation Markers Market

  • 20.1. Spain Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Coagulation Markers Market

  • 21.1. Eastern Europe Coagulation Markers Market Overview
  • 21.2. Eastern Europe Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Coagulation Markers Market

  • 22.1. Russia Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Coagulation Markers Market

  • 23.1. North America Coagulation Markers Market Overview
  • 23.2. North America Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Coagulation Markers Market

  • 24.1. USA Coagulation Markers Market Overview
  • 24.2. USA Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Coagulation Markers Market

  • 25.1. Canada Coagulation Markers Market Overview
  • 25.2. Canada Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Coagulation Markers Market

  • 26.1. South America Coagulation Markers Market Overview
  • 26.2. South America Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Coagulation Markers Market

  • 27.1. Brazil Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Coagulation Markers Market

  • 28.1. Middle East Coagulation Markers Market Overview
  • 28.2. Middle East Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Coagulation Markers Market

  • 29.1. Africa Coagulation Markers Market Overview
  • 29.2. Africa Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Coagulation Markers Market Competitive Landscape And Company Profiles

  • 30.1. Coagulation Markers Market Competitive Landscape
  • 30.2. Coagulation Markers Market Company Profiles
    • 30.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Coagulation Markers Market Other Major And Innovative Companies

  • 31.1. Sysmex Corporation
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Werfen Group
  • 31.4. Nihon Kohden Corporation
  • 31.5. Randox Laboratories Ltd
  • 31.6. Stago Group
  • 31.7. Sekisui Diagnostics
  • 31.8. Helena Laboratories Italia Spa
  • 31.9. Tulip Diagnostics Ltd
  • 31.10. Trinity Biotech PLC
  • 31.11. CTK Biotech Inc.
  • 31.12. International Technidyne Corporation (ITC)
  • 31.13. Diazyme Laboratories Inc.
  • 31.14. AdvaCare Pharma USA (AccuQuik Test Kits)
  • 31.15. Technoclone GmbH

32. Global Coagulation Markers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coagulation Markers Market

34. Recent Developments In The Coagulation Markers Market

35. Coagulation Markers Market High Potential Countries, Segments and Strategies

  • 35.1 Coagulation Markers Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Coagulation Markers Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Coagulation Markers Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer